NEOG Neogen Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: NEOG

Price (delayed)

$12.295

Market cap

$2.68B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.04

Enterprise value

$3.29B

?
Relative Growth: Rel. Growth: 55
Relative Strength: Rel. Strength: 93
Relative Valuation: Rel. Valuation: 24
Relative Profitability: Rel. Profitability: 50

Neogen Corporation is committed to fueling a brighter future for global food security through the advancement of human and animal well-being. Harnessing the power of science and technology, Neogen has ...

Highlights
The EPS has soared by 99% year-on-year and by 99% since the previous quarter
Neogen's net income has soared by 99% YoY and by 99% from the previous quarter
The gross profit is up by 3.8% from the previous quarter but it is down by 3.1% YoY
The revenue has contracted by 2.7% YoY
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.neogen.com
Peers: IDXX ILMN TMO PACB

Key stats

What are the main financial stats of NEOG

NEOG stock price

How has the Neogen stock price performed over time
Intraday
2.12%
1 week
31.64%
1 month
31.64%
1 year
163.84%
YTD
75.89%
QTD
36.76%

Financial performance

How have Neogen's revenue and profit performed over time
Revenue
$870.4M
Gross profit
$408.5M
Operating income
-$21.6M
Net income
-$7.9M
Gross margin
46.9%
Net margin
-0.9%
Neogen's net income has soared by 99% YoY and by 99% from the previous quarter
The net margin has soared by 99% year-on-year and by 99% since the previous quarter
The operating margin has soared by 98% year-on-year and by 97% since the previous quarter
The company's operating income has surged by 98% YoY and by 97% QoQ

Price vs fundamentals

How does NEOG's price correlate with its fundamentals

Growth

What is Neogen's growth rate over time

Valuation

What is Neogen stock price valuation
NEOG P/E details
P/E
N/A
P/B
1.28
P/S
3.07
EV/EBIT
67.68
EV/EBITDA
19.29
EV/Sales
3.78
The EPS has soared by 99% year-on-year and by 99% since the previous quarter
The P/B is 56% more than the last 4 quarters average of 0.8 but 31% less than the 5-year quarterly average of 1.8
The price to sales (P/S) is 51% higher than the last 4 quarters average of 2.0 but 30% lower than the 5-year quarterly average of 4.3
The revenue has contracted by 2.7% YoY

Efficiency

How efficient is Neogen business performance
The return on invested capital has surged by 109% since the previous quarter and by 105% year-on-year
The ROS has soared by 109% since the previous quarter and by 105% year-on-year
Neogen's return on equity has surged by 99% YoY and by 99% QoQ
The ROA has soared by 99% year-on-year and by 99% since the previous quarter

Dividends

What is NEOG's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NEOG.

Financial health

How did Neogen financials performed over time
The total assets is 167% more than the total liabilities
The quick ratio is up by 30% year-on-year and by 7% since the previous quarter
NEOG's current ratio is up by 15% YoY but it is down by 2.6% QoQ
The debt is 62% smaller than the equity
The company's debt to equity fell by 12% YoY
The debt is down by 11% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.